Table 2.
Characteristics of patients with gastric cancer.
| CD271 | − (N = 17) | + (N = 20) | p-value1 |
|---|---|---|---|
| Age, Median (IQR) | 69 (68–73) | 69 (63–71) | 0.17 |
| Gender (%) | > 0.99 | ||
| Female | 1 (5.9) | 2 (10) | |
| Male | 16 (94) | 18 (90) | |
| pp65 (%) | 0.014 | ||
| − | 5 (29) | 0 (0) | |
| + | 12 (71) | 20 (100) | |
| cSTAGE (%) | 0.38 | ||
| 1 | 2 (12) | 5 (25) | |
| 2 | 3 (18) | 4 (20) | |
| 3 | 0 (0) | 2 (10) | |
| 4 | 12 (71) | 9 (45) | |
| cT (%) | 0.84 | ||
| T1 | 3 (18) | 6 (30) | |
| T2 | 6 (35) | 7 (35) | |
| T3 | 4 (24) | 4 (20) | |
| T4 | 4 (24) | 3 (15) | |
| cN (%) | 0.61 | ||
| N0 | 7 (41) | 11 (55) | |
| N1 | 0 (0) | 1 (5.0) | |
| N2 | 8 (47) | 7 (35) | |
| N3 | 2 (12) | 1 (5.0) | |
| cM (%) | 0.2 | ||
| M0 | 15 (88) | 20 (100) | |
| M1 | 2 (12) | 0 (0) |
1Wilcoxon rank sum exact test; Fisher's exact test.